Dominantly Inherited Alzheimer Network: Facilitating Research And Clinical Trials

Document Type

Journal Article

Publisher

Future Science Group

Faculty

Faculty of Health, Engineering and Science

School

School of Medical Sciences / Centre of Excellence for Alzheimer's Disease Research and Care

Comments

Morris, J. C., Aisen, P. S., Bateman, R. J., Benzinger, T. L., Cairns, N. J., Fagan, A. M., ... & Buckles, V. D. (2012). Developing an international network for Alzheimer's research: the Dominantly Inherited Alzheimer Network. Clinical investigation, 2(10), 975-984. Original article is available here

Abstract

The Dominantly Inherited Alzheimer Network (DIAN) is a collaborative effort of international Alzheimer’s Disease (AD) Centers that are conducting a multifaceted prospective biomarker study in individuals at risk for autosomal dominant AD. The DIAN collects comprehensive information and tissue in accordance with standard protocols from asymptomatic and symptomatic autosomal dominant AD mutation carriers and their noncarrier family members to determine the pathochronology of clinical, cognitive, neuroimaging and fluid biomarkers of AD. This article describes the structure, implementation and underlying principles of the DIAN, as well as the demographic features of the initial DIAN cohort.

DOI

10.4155/cli.12.93

Access Rights

subscription content

Share

 
COinS